361 related articles for article (PubMed ID: 25805945)
1. New therapeutic option for irritable bowel syndrome: serum-derived bovine immunoglobulin.
Good L; Rosario R; Panas R
World J Gastroenterol; 2015 Mar; 21(11):3361-6. PubMed ID: 25805945
[TBL] [Abstract][Full Text] [Related]
2. Episodic nature of symptoms in irritable bowel syndrome.
Palsson OS; Baggish J; Whitehead WE
Am J Gastroenterol; 2014 Sep; 109(9):1450-60. PubMed ID: 24980882
[TBL] [Abstract][Full Text] [Related]
3. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
4. Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective.
Shaw AL; Tomanelli A; Bradshaw TP; Petschow BW; Burnett BP
Patient Prefer Adherence; 2017; 11():1001-1007. PubMed ID: 28615929
[TBL] [Abstract][Full Text] [Related]
5. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.
Valentin N; Camilleri M; Carlson P; Harrington SC; Eckert D; O'Neill J; Burton D; Chen J; Shaw AL; Acosta A
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275113
[TBL] [Abstract][Full Text] [Related]
6. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M; Lembo A; Chey WD; Zakko S; Ringel Y; Yu J; Mareya SM; Shaw AL; Bortey E; Forbes WP;
N Engl J Med; 2011 Jan; 364(1):22-32. PubMed ID: 21208106
[TBL] [Abstract][Full Text] [Related]
8. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
Hawrelak JA; Myers SP
J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
[TBL] [Abstract][Full Text] [Related]
9. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
[TBL] [Abstract][Full Text] [Related]
10. Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome.
Arrouk R; Herdes RE; Karpinski AC; Hyman PE
Pediatric Health Med Ther; 2018; 9():129-133. PubMed ID: 30498390
[TBL] [Abstract][Full Text] [Related]
11. Treatment of irritable bowel syndrome with a novel colonic irrigation system: a pilot study.
Hsu HH; Leung WH; Hu GC
Tech Coloproctol; 2016 Aug; 20(8):551-7. PubMed ID: 27194235
[TBL] [Abstract][Full Text] [Related]
12. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
13. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
Houghton LA; Lea R; Agrawal A; Reilly B; Whorwell PJ
Gastroenterology; 2006 Oct; 131(4):1003-10. PubMed ID: 17030170
[TBL] [Abstract][Full Text] [Related]
14. Bovine immunoglobulin protein isolates for the nutritional management of enteropathy.
Petschow BW; Blikslager AT; Weaver EM; Campbell JM; Polo J; Shaw AL; Burnett BP; Klein GL; Rhoads JM
World J Gastroenterol; 2014 Sep; 20(33):11713-26. PubMed ID: 25206275
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome.
Wilson D; Evans M; Weaver E; Shaw AL; Klein GL
Clin Med Insights Gastroenterol; 2013; 6():49-60. PubMed ID: 24833942
[TBL] [Abstract][Full Text] [Related]
17. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
18. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.
Palsson OS; Baggish JS; Turner MJ; Whitehead WE
Am J Gastroenterol; 2012 Feb; 107(2):286-95. PubMed ID: 22068664
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
Drossman DA; Morris C; Hu Y; Leserman J; Dalton C; Toner B; Diamante N; Bangdiwala S
J Clin Gastroenterol; 2008; 42(10):1080-8. PubMed ID: 18949838
[TBL] [Abstract][Full Text] [Related]
20. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
